This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Seasonal Affective Disorder
and you are
between 21 and 64
years old
The phase for this study is not defined.
Show me locations

The purpose

The primary objective of this study is to evaluate the effect of light therapy using a narrow 467nm light compared to a 580nm light in subjects with Seasonal Affective Disorder (SAD). It is hypothesized that the 467nm light will improve the symptoms of SAD better than the 580nm light.

Provided treatments

  • Device: goLITE
  • Device: Control

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01462305. The sponsor of the trial is Philips Respironics and it is looking for 35 volunteers for the current phase.
Official trial title:
30-Minute Light Exposure for the Treatment of Seasonal Affective Disorder